<DOC>
	<DOCNO>NCT02415894</DOCNO>
	<brief_summary>The goal study examine effectiveness feasibility mifepristone-misoprostol medical abortion regimen terminate pregnancy 13-22 week Ukraine .</brief_summary>
	<brief_title>Mifepristone Misoprostol Mid-trimester Termination Pregnancy Ukraine</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Having ongoing pregnancy 1322 week gestation Be willing undergo surgical completion necessary Have contraindication study procedure , accord provider Be willing able consent participate study Be willing follow study procedure Known allergy mifepristone misoprostol/prostaglandin Any contraindication vaginal delivery , include placenta previa Unable provide consent</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>